CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $233,000 | -5.3% | 13,400 | -8.2% | 0.04% | -25.0% |
Q2 2020 | $246,000 | +41.4% | 14,600 | 0.0% | 0.06% | +115.4% |
Q1 2020 | $174,000 | -1.7% | 14,600 | 0.0% | 0.03% | +30.0% |
Q4 2019 | $177,000 | -14.1% | 14,600 | 0.0% | 0.02% | -13.0% |
Q3 2019 | $206,000 | +26.4% | 14,600 | 0.0% | 0.02% | +35.3% |
Q2 2019 | $163,000 | -4.7% | 14,600 | 0.0% | 0.02% | -22.7% |
Q1 2019 | $171,000 | -12.3% | 14,600 | 0.0% | 0.02% | -21.4% |
Q4 2018 | $195,000 | -4.9% | 14,600 | 0.0% | 0.03% | +40.0% |
Q3 2018 | $205,000 | -10.9% | 14,600 | 0.0% | 0.02% | -31.0% |
Q2 2018 | $230,000 | -4.2% | 14,600 | 0.0% | 0.03% | -3.3% |
Q1 2018 | $240,000 | -21.8% | 14,600 | -14.1% | 0.03% | -26.8% |
Q4 2017 | $307,000 | -11.0% | 17,000 | -5.0% | 0.04% | +2.5% |
Q3 2017 | $345,000 | +32.7% | 17,900 | -18.6% | 0.04% | +42.9% |
Q2 2017 | $260,000 | -13.6% | 22,000 | -20.0% | 0.03% | -17.6% |
Q1 2017 | $301,000 | +17.6% | 27,500 | -21.9% | 0.03% | +13.3% |
Q4 2016 | $256,000 | -55.2% | 35,200 | -60.0% | 0.03% | -55.2% |
Q3 2016 | $572,000 | +9.8% | 88,000 | -7.9% | 0.07% | -1.5% |
Q2 2016 | $521,000 | +15.8% | 95,500 | -0.7% | 0.07% | +21.4% |
Q1 2016 | $450,000 | -6.1% | 96,200 | 0.0% | 0.06% | -1.8% |
Q4 2015 | $479,000 | +32.3% | 96,200 | 0.0% | 0.06% | +11.8% |
Q3 2015 | $362,000 | -37.4% | 96,200 | 0.0% | 0.05% | -38.6% |
Q2 2015 | $578,000 | +5.3% | 96,200 | -1.8% | 0.08% | -9.8% |
Q1 2015 | $549,000 | +83.0% | 98,000 | -2.0% | 0.09% | +114.0% |
Q4 2014 | $300,000 | +11.9% | 100,000 | 0.0% | 0.04% | 0.0% |
Q3 2014 | $268,000 | -4.3% | 100,000 | 0.0% | 0.04% | -28.3% |
Q2 2014 | $280,000 | -35.8% | 100,000 | 0.0% | 0.06% | -49.6% |
Q1 2014 | $436,000 | +35.8% | 100,000 | 0.0% | 0.12% | +2.6% |
Q4 2013 | $321,000 | +101.9% | 100,000 | 0.0% | 0.12% | +241.2% |
Q3 2013 | $159,000 | -8.1% | 100,000 | 0.0% | 0.03% | -26.1% |
Q2 2013 | $173,000 | – | 100,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |